Senseonics signs local asset purchase agreements for Eversense CGM business in Italy, Germany, Spain, and Sweden

Senseonics Holdings, Inc.

On March 12, 2026, Senseonics entered into Local Purchase Agreements to acquire Ascensia's Eversense CGM assets in four European countries.
Consideration is cash payment of Net Book Value; closing expected on or before June 30, 2026.
Transition Services Agreement signed to support logistics, IT, regulatory, and commercial continuity through June 30, 2026.
Transactions were contemplated by the Master Asset Purchase Agreement with Ascensia disclosed on January 2, 2026.
Company assumes commercial responsibility for Eversense in European Territories, subject to customary closing conditions.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Senseonics Holdings, Inc. entered into Local Asset Purchase Agreements with Ascensia Diabetes Care Holdings AG valued at Cash payment of respective Net Book Value (effective 2026-03-12).

Action: entry
Agreement: asset purchase
Counterparty: Ascensia Diabetes Care Holdings AG
Value: Cash payment of respective Net Book Value
Effective: 2026-03-12

Exact text from the filing

On March 12, 2026, the Purchaser Parties and the Seller Parties entered into the Local Purchase Agreements, pursuant to which, among other things, the Purchaser Parties agreed to acquire Seller’s and as applicable, Seller Parties’, right, title and interest in and to the European Purchased Assets and to assume the European Assumed Liabilities, as contemplated by the Master Asset Purchase Agreement.

View on SEC.gov

299 material agreements filed in the last 30 days. Browse all material agreements →

Senseonics Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-027055

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.